John Ballantyne insider trades
Open-market stock purchases and sales by John Ballantyne, Director, 10% Owner at Glucotrack, Inc, from SEC Form 4 filings since Jul 30, 2024.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- GCTK Glucotrack, Inc: 3 buys, last Mar 26, 2025